BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37981503)

  • 21. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable survival benefits of partial ureterectomy to radical nephroureterectomy in non-metastatic ureter carcinoma: a population-matched study.
    Qiu Y; Zhang X; Dong Z; Zhang Y; Zhai Q; Lv S; Wei Q
    Int Urol Nephrol; 2023 Mar; 55(3):579-588. PubMed ID: 36472798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.
    Dudinec JV; Ortiz-Melo DI; Lipkin ME; Abern MR; Shah AM; Inman BA
    Urol Oncol; 2023 Jun; 41(6):295.e19-295.e25. PubMed ID: 36526526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.
    Fang C; Xie X; Xu T; He W; He H; Wang X; Zhu Y; Shen Z; Shao Y
    Int Urol Nephrol; 2017 Jul; 49(7):1177-1182. PubMed ID: 28343326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
    J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segmental ureterectomy can be performed safely in patients with urothelial carcinoma of distal ureter.
    Jia Z; Gong YQ; Zhang CJ; Bao ZQ; Li XS; Hao H; Xiong GY; Zhang L; Fang D; He ZS; Zhou LQ
    Can Urol Assoc J; 2019 Jul; 13(7):E202-E209. PubMed ID: 30472983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney-sparing surgery for distal high-risk ureteral carcinoma: Clinical efficacy and preliminary experiences in 22 patients.
    Jiang Y; Peng Y; Ding S; Zheng Y; He Y; Liu J
    Cancer Med; 2023 Apr; 12(7):7835-7843. PubMed ID: 36533431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
    Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
    Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney-sparing surgery for upper tract urothelial cancer.
    Lucca I; Klatte T; Rouprêt M; Shariat SF
    Curr Opin Urol; 2015 Mar; 25(2):100-4. PubMed ID: 25581542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.
    Masson-Lecomte A; Colin P; Bozzini G; Nison L; de La Taille A; Comperat E; Zerbib M; Rozet F; Cathelineau X; Valeri A; Ruffion A; Guy L; Droupy S; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):531-7. PubMed ID: 23907662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of routine frozen section analysis during nephroureterectomy or segmental ureterectomy for urothelial carcinoma on final surgical margin status and long-term oncologic outcome.
    Lima W; Wang Y; Miyamoto H
    Urol Oncol; 2023 Aug; 41(8):357.e1-357.e9. PubMed ID: 37142451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic outcomes comparison of partial ureterectomy and radical nephroureterectomy for urothelial carcinoma.
    Li S; Pan Y; Hu J
    BMC Urol; 2019 Nov; 19(1):120. PubMed ID: 31752789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.